Glenmark - Tear Sheet - Lucror Analytics
We view Glenmark Pharmaceuticals as “Medium Risk” on the LARA scale. Our opinion is primarily based on the company’s sound track record of...
48 Views
Asia HY Trade Recommendations - September 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for September includes a summary of our recommendations, as well as our high-conviction ideas. We also...
76 Views
Lucror Analytics - Morning Views Asia - 18 Sep 2019
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
64 Views
Asia HY Monthly - Chinese Property Update - Lucror Analytics
In this month’s “In-Focus” section, we provide an update on the Chinese property sector, including trends in contracted sales and operations, as...
85 Views
Asia HY Trade Recommendations - August 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for August includes a summary of our recommendations, as well as our high-conviction ideas. We also...
66 Views